Point-of-care Cholesterol Monitoring Device Market

Growing Geriatric Population

Higher lipoprotein level is a major cardiovascular risk factor that increases the occurrence of wide range of diseases in adults. Unhealthy lifestyle is the major factor in the developed and developing countries resulting in high level of cholesterol, which further increases the incidence of cardiovascular diseases.

The geriatric population is at major risk of high cholesterol level, which can lead to problems such as arteriosclerosis, cardiac arrest, etc. Regular monitoring of cholestrol levels through cholesterol monitors such as point-of-care cholesterol monitoring devices as well as through HDL cholesterol kits are necessary to adoid sudden cardiac arrest. Thus, the growing geriatric population is expected to increase the demand for point-of-care cholesterol monitoring device over the forecast period.

Shift towards Self-testing

The cholesterol home test devices and kits are convenient and effective for testing the cholesterol level. The point-of-care cholesterol monitoring device help to check the cholesterol level conveniently at home. The point-of-care cholesterol monitoring device displays the result in few minutes. The use of point-of-care cholesterol monitoring device is a cost-effective way, it helps in early detection and reduces the chance of developing further complications. Therefore, the demand for self-testing kits for at home use is growing nowadays.

Evolving Amendments & Stringent Regulatory Scenarios

The stringent government regulations for approval of any new device in the market is one of the major challenges faced by almost all the countries. Certain amendments have been designed by regulatory policies in the recent years to address the lack of standardization in device portfolio. The stringent protocol for device approvals such as licensing, assessing the safety, and inspection are considered to be a time consuming process for the manufacturers.

Regulatory issues are impediments to local device manufacturers. The stringent regulatory policies associated with point-of-care cholesterol monitoring device are expected to hamper the growth of the global point-of-care cholesterol monitoring device market.

Competitive Landscape

This section of the report features profiles of key players operating in the point-of-care cholesterol monitoring device market based on their market share, product offerings for point-of-care cholesterol monitoring device, differential strategies, company dashboard and marketing approach. Examples of some of the key players featured in this report include F. Hoffmann-La Roche Ltd., Acon Laboratories, Inc., Abaxis, Inc., Abbott Laboratories, SD Biosensor, Inc., Jant Pharmacal Corporation, DiaSys Diagnostic Systems GmbH, Bioptik Ltd., and Fitech UK Ltd., among others.

These companies offer a wide range of point-of-care cholesterol monitoring device and testing kits. The emerging players operating in the point-of-care cholesterol monitoring device market are majorly focusing on new marketing strategies in order to expand their product footprint in the global point-of-care cholesterol monitoring device market.

Download a Comprehensive Report Snapshot

Definition

Point-of-care cholesterol monitoring device is used for rapid detection of blood analytes for rapid diagnosis & management. It is a modern-day device that enables the user to perform diagnostic test outside the laboratory. The device is small and portable used to obtain results of blood cholesterol & lipoprotein levels. The device detects total cholesterol profile, including HDL, LDL & Triglycerides. It comes in two types, namely Bench-top and Hand-held devices.

About the Report

The report offers a comprehensive evaluation of the business opportunities in the point-of-care cholesterol monitoring device market along with insights that elaborate the macroeconomic factors influencing the dynamics of the point-of-care cholesterol monitoring device market, and its futuristic potential.

Additional Questions Answered

Some of the additional questions addressed in this report on point-of-care cholesterol monitoring device market-

• What is the revenue potential of point-of-care cholesterol monitoring device market across regions of North America and Europe?
• Who are the key competitors in the point-of-care cholesterol monitoring device market and what are their portfolios?
• What are the major challenges influencing the growth of the point-of-care cholesterol monitoring device market?
• How is intervention from regulatory authorities shaping the point-of-care cholesterol monitoring device market growth?

Research Methodology

The point-of-care cholesterol monitoring device market has been estimated based on the supply-demand approach. A triangulation methodology is adopted to derive the point-of-care cholesterol monitoring device market size, which is primarily based on overall expenditure on capital equipment installed base , life science research and  R&D funding to obtain precise market estimations and insights on life science and biotechnology associated services ,  products, technologies and  applications.

This information is further validated with rigorous primary research (including interviews, surveys, in-person interactions, and viewpoints of seasoned analysts) and secondary research (including verified paid sources, authentic trade journals, and resourceful databases).

Segmentation

The report offers a comprehensive taxonomy of the point-of-care cholesterol monitoring device market on the basis of product type, technology, application, end user and region. On the basis of product type, the global point-of-care cholesterol monitoring device market has been segmented into point-of-care cholesterol monitoring device instruments and testing kits. On the basis of technology, the global point-of-care cholesterol monitoring device market has been segmented into electrochemical biosensor and reflectance photometry.

On the basis of application, the point-of-care cholesterol monitoring device market is segmented as dyslipidemia, arteriosclerosis, hypercholesterolemia, hypocholesterolemia and others. Geographically, the point-of-care cholesterol monitoring device market has been segmented into North America, Latin America, Western Europe, Eastern Europe, Asia Pacific excluding China and Japan, China, Japan and Middle East & Africa (MEA).